We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Nova Biomedical

Nova is a world leader in the development and manufacturing of whole blood, point-of-care and critical care analyzers... read more Featured Products: More products

Download Mobile App




Blood Gas Analyzer Simplifies Critical Care Testing

By LabMedica International staff writers
Posted on 22 Apr 2014
A new blood gas analyzer combines revolutionary microelectronics with maintenance cartridge technology for a smaller, faster, and less expensive critical care analyzer. More...


The Stat Profile Prime blood gas analyzer uses MicroSensor Card technology, which contains biosensors for acidity (pH), partial CO2 (PCO2), partial O2 (PO2), sodium (Na), potassium (K), ionized calcium (iCa), chloride (Cl), glucose, lactate, and hematocrit. The MicroSensor Card is automatically calibrated and is always ready to deliver a full 10-test profile in just 60 seconds. Thanks to ZERØ maintenance technology— which consists of individual cartridges for biosensors, calibrators, and liquid quality control—and continuous electronic self-monitoring, each cartridge is maintenance-free, ready to use, and easily replaced in seconds.

MicroSensor cards can be replaced in less than half the time of older cartridge systems, optimizing the life of each cartridge, improving analyzer uptime, and eliminating the waste, downtime, and higher costs of combined calibrator/sensor cartridge systems, which can take more than an hour to calibrate and can remain unstable with drift, frequent recalibrations, and reduced throughput for even longer periods of time. Proprietary ClotBlock sample flow path technology protects the MicroSensor Card from blockages and prolonged downtime caused by blood clots. The Stat Profile Prime blood gas analyzer is a product of Nova Biomedical (Waltham, MA, USA).

“We at Nova Biomedical are extremely excited to launch the Stat Profile Prime platform with the Prime critical care system,” said Brad Bullen, BS, RCP, sales product line manager at Nova Biomedical. “Stat Profile Prime represents the latest critical care testing technology and further demonstrates Nova’s leadership and history of innovation. Our zero maintenance system allows its users to focus on what is important - patient care.”

Related Links:

Nova Biomedical



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Nasopharyngeal Applicator
CalgiSwab 5.5" Sterile Mini-tip Calcium Alginate Nasopharyngeal Swab w/Aluminum HDLE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.